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Abstract
A functional disorder is a medical condition that impairs the normal function, but 
­without­major­organic­cause­such­as­irritation­or­inflammation­and­where­the­organ­or­
part of the body looks completely normal under medical examination. The accumula-
tion of abnormalities that limit body functions is a major risk factor for patients with 
irritable­bowel­ syndrome­ (IBS),­defined­as­a­gastrointestinal­disorder­with­abdominal­
pain or discomfort that is associated with a change in bowel habit. Often, this disorder is 
accompanied by the concomitant decline in cognitive or motor performance. Pain that in 
some­patients­is­out­of­proportion­to­identifiable­pathology­is­the­most­immediate­and­
dramatic consequence of IBS and is responsible for a highly negative impact on quality 
of life and substantial workforce loss. For patients with IBS, the most common comorbid 
diagnoses include painful bladder syndrome (PBS) or chronic pelvic pain (CPP). Cells of 
the­affected­tissues­may­interact­in­cell-to-cell­manner­messages­through­the­transfer­of­
hormones,­cytokines,­and­other­mediators­that­influence­normal­functioning.­The­com-
plex interplay and balance between these diverse mediators, ageing, genetic background, 
and environmental factors may ultimately determine the outcome of the progression of 
the functional disorder. On a cellular level, these responses are highly complex, involv-
ing a vast array of enzymes and receptors of virtually every class, directing recruitment 
of many types of cells to recover the healthy state. Indeed, a balance between the mes-
sengers­with­the­inherent­redundancy­of­the­different­body­systems­makes­therapeutic­
intervention of functional disorders a considerable challenge.
Keywords:­sensory­neurons,­extrinsic­primary­afferents,­nociception
1. Introduction
The­ response­ properties­ of­ pelvic­ extrinsic­ primary­ afferent­ nerves­ (EPANs)­ play­ an­
important role in etiology of irritable bowel syndrome (IBS). Hypersensitivity of visceral 
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­mechanoreceptors­could­result­from­excessive­production­of­modulatory­neurotransmitters.­
In­addition­ to­direct­stimulation­of­stretch-activated­channels­on­primary­afferent­neurons­
located­in­dorsal­root­ganglia­(DRG),­chemicals­produced­by­different­target­cells­ (such­as­
smooth­muscle­cells­and­interstitial­cells­of­Cajal)­in­response­to­stretch­or­inflammation­play­
an important role in the neuromodulation of nociception. The incidence of  persistent,  episodic, 
or chronic visceral pain is more prevalent in females, which also suggests hormonal regula-
tion.­Despite­extensive­research­of­the­properties­of­pelvic­and­splanchnic­afferent­nerves,­lit-
tle is known about the mechanisms underlying normal and pathological signal transduction 
pathways­underlying­many­functional­diseases.­Despite­considerable­efforts­by­the­scientific­
community and the pharmaceutical industry to develop novel pharmacological treatments 
aimed at chronic visceral pain, the traditional approaches to identifying and evaluating novel 
drugs­for­this­target­have­largely­failed­to­translate­into­effective­IBS­treatments­[1].­A­better­
understanding­of­these­processes­has­direct­implications­for­the­development­of­more­effec-
tive­therapies.­During­the­last­decade,­we­identified­that­DRG­neurons­can­be­affected­by­ATP,­
NO,­estrogen,­and­other­mediators­producing­neuronal­hyper-­or­desensitization­that­may­
unravel the enigma of the development of chronic pelvic pain associated with IBS. Moreover, 
our­recent­data­that­estrogen­can­gate­primary­afferent­response­to­modulate­nociception­sup-
port the idea about involvement of peripheral central system in etiology of a wide range of the 
functional­and­inflammatory­gastrointestinal­diseases­[2].
2. Role of EPANs in the mechanisms of visceral neurotransduction 
and modulation
Pelvic­nerve­ afferent­fibers­ innervating­ the­visceral­ organs­of­ the­ lower­ colon­have­been­
well­characterized­(reviewed­in­Ref.­[3]). In general, during colonic distension, a large num-
ber­of­pelvic­EPANs­show­static­ levels­of­discharge.­Stretches­that­lead­to­the­opening­of­
 stretch-activated (SA) channels on the plasma membrane lead to the selective or nonse-
lective­ opening­ of­ different­ cation­ and­ anion­ channels­ in­ nodose­ ganglia­ and­DRG­neu-
rons.­Thus,­depending­on­the­cell­type­and­channel­type,­EPANs­activation­may­result­in­
hyperpolarization, depolarization, or primarily Ca2+­influx.­The­function­of­SA­channels­in­
the­plasma­membrane­differs­between­various­cell­types.­Influx­of­Ca2+ may repolarize the 
plasma membrane via activation of K
ca 
channels and inactivating of voltage-gated calcium 
channels­(VGCCs),­and­thus­influence­adaptation­rates­of­sensory­neurons­during­ongoing­
stimulations.
The­ cell­ bodies­ of­primary­visceral­ spinal­ afferent­neurons­ are­ located­ in­ the­ lumbosacral­
(L1-S1) DRGs that transmit information about chemical or mechanical stimulation from the 
periphery­ to­ the­ spinal­ cord.­Nociceptors­ are­ small-­ to­medium-size­DRG­neurons­whose­
peripheral processes detect potentially damaging physical and chemical stimuli. Until 
recently, ATP release from nonneuronal cells was thought to be exclusively as result of injury. 
It­is­now­clear­that­certain­integral­membrane­proteins­contain­an­ATP-binding­cassette­so­this­
Irritable Bowel Syndrome - Novel Concepts for Research and Treatment2
neurotransmitter­can­act­as­signaling­molecule­modulating­sensory­afferent­nerve­terminals.­
Six­P2X­receptors­are­expressed­in­DRGs.­Significantly,­the­P2X3­receptor­is­found­exclusively­
in a subset of small diameter capsaicin sensitive peripheral sensory neurons (presumably 
nociceptors)­[4]. Today, multiple lines of evidence suggest that ATP signaling via P2X recep-
tors­contribute­to­different­pain­phenotypes,­therefore­P2X­antagonists­may­be­useful­analge-
sics.­The­availability­of­P2X­receptor-specific­antagonists­also­holds­the­promise­of­revealing­
the cellular and molecular neurobiology underlying pain states underlying functional dis-
eases­ [5].­With­ sufficiently­high­ levels­ of­ATP,­P2X­and­SA­ channels­ (which­has­ a­greater­
permeability for Ca2+­than­Na+) would depolarize nerve terminals directly producing action 
potentials­and­leading­to­sensation­of­pain.­On­the­other­hand,­the­response­of­EPANs­may­
be­tonically­inhibited­by­NO­produced­by­peripheral­nerve­terminals.­The­peripheral­sensi-
tization­of­nerve­fibers­is­transient­depending­on­the­duration­of­stimuli­and­the­presence­of­
visceral­(colonic)­inflammation.
3. Estrogen receptors and visceral nociception associated with 
functional diseases
Changes in pain perception and variations of symptoms throughout the menstrual cycle, as 
well­as­sexual­intercourse­triggering­symptoms­in­a­significant­portion­of­females­diagnosed­
with irritable bowel syndrome (IBS), painful bladder syndrome (PBS), chronic pelvic pain 
(CPP), and other function syndromes, points to a connection with sex steroids. Several lines 
of­evidence­indicate­that­17β-estradiol­(E2)­directly­influence­the­functions­of­primary­affer-
ent­neurons.­Both­subtypes­of­estrogen­receptors­(ERα­and­ERβ)­are­present­in­DRG­neurons­
including­the­small-diameter­putative­nociceptors­[4]. In vitro, ATP-sensitive DRG neurons 
respond­to­E2­[6, 7],­which­correlated­well­with­the­idea­that­visceral­afferents­are­E2­sensitive:­
(i)­visceral­pain­is­affected­by­hormonal­level­in­cycling­females;­(ii)­there­are­sex­differences­
in­the­prevalence­of­functional­disorders­involving­the­viscera;­and­(iii)­putative­visceral­affer-
ents­fit­into­the­population­of­DRG­neurons­that­are­sensitive­to­E2­[7]. These data suggest 
that­in­addition­to­the­CNS­actions,­E2­can­act­in­the­periphery­to­modulate­nociception­[6, 7]. 
E2­modulates­cellular­activity­by­altering­ion­channel­opening,­G-protein­signaling,­and­acti-
vation­of­trophic­factor-like­signal­transduction­pathways.­These­effects­have­been­ascribed­
to­membrane-associated­receptors­ [8]. The results from our laboratory and others indicate 
that­E2­acts­in­DRG­neurons­to­modulate­L-type­VGCC­and­through­group­II­metabotropic­
glutamate­receptors­[6].
E2­has­a­significant­role­in­modulating­visceral­sensitivity,­ indicating­that­E2­alterations­in­
sensory­ processing­ may­ underlie­ sex-based­ differences­ in­ functional­ pain­ symptoms­ [9]. 
Indeed in most clinical studies, women report more severe pain levels, more frequent pain, 
and­longer­duration­of­pain­than­men­[10].­Little­is­known­about­E2-mediated­mechanisms­
in­peripheral­nervous­system,­but­the­fact­that­DRG­neurons­express­ERs­and­respond­to­E2­
treatment­suggest­that­they­are­a­potential­target­for­mediating­nociception.­E2­modulation­of­
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nociceptive response depends on the type of pain, its durations, and the involvement of other 
nociceptive-mediated mechanisms.
E2­(both­short-term­and­long-term­exposure)­significantly­decreased­the­nociceptive­signal-
ing­in­viscerally­labeled­DRG­neurons­[6, 7]. Thus, in addition to central regulation, estrogen 
may­affect­nociception­associated­with­IBS­peripherally.
4. Primary afferent neurons and viscero-visceral cross-sensitization: 
emerging model for functional gastrointestinal disorders
Most­ of­ the­ current­ literature­ pertains­ to­ specific­ functional­ syndromes­ defined­ by­medi-
cal­subspecialties.­These­ include:­ IBS­ (gastroenterology);­CPP­(gynecology);­PBS­(­urology);­
fibromyalgia­ (rheumatology);­ and­ others.­ Many­ reports­ described­ the­ substantial­ over-
laps­between­ two­or­more­of­ these­syndromes­ [11, 12]. Moreover, clinical presentations of 
functional­syndromes­lack­a­specific­pathology­in­the­affected­organ­but­may­respond­to­a­
viscero-visceral­ cross-sensitization­ in­which­ increased­nociceptive­ input­ from­an­ inflamed­
organ­(i.e.,­uterus)­sensitizes­neurons­that­receive­convergent­input­from­an­unaffected­organ­
(i.e., colon or  bladder). The site of visceral cross-sensitivity is unknown.
Recent studies from our laboratory demonstrated that hormonal modulation of visceral 
inputs­of­primary­afferent­nociceptors­ located­ in­ the­dorsal­ root­ganglia­ (DRG)­ is­ respon-
sible for changes observed in the perception of pain during the etiology of functional pain 
syndromes­[2].­Individuals­suffering­from­CPP­frequently­have­pain­emanating­from­several­
visceral organs. Viscero-somatic and viscero-visceral hyperalgesia and allodynia lead to the 
perception of pain spreading from an initial site to adjacent areas. Patients with CPP may 
at­first­have­only­one­source­of­pain­in­the­pelvis,­but­numerous­mechanisms­involving­the­
central and peripheral nervous systems may result in the development of painful sensations 
in adjacent organs, such as IBS being associated with lower colonic pain.
5. Summary
Similar to other chronic diseases, a multicomponent conceptual model of IBS, which involves 
physiologic, cognitive and behavior factors will be necessary for developing new therapies. 
The­different­systems­such­as­neuroendocrine­regulation,­pain­modulation,­and­autonomic­
response­will­affect­ascending­aminergic­systems­(Figure 1).
From a public health perspective, a substantial impact on our knowledge of nociceptive 
diseases such IBS will help achieve a deeper understanding of data presented in clini-
cal aspects of these symptoms. Only a thorough understanding of the mechanism impli-
cated­in­these­phenomena­can­truly­contribute­to­the­designing­of­new­and­more­efficient­
therapies.
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